https://www.businesswire.com/news/home/20260111738818/en/Aelis-Farma-Receives-a-Positive-Opinion-From-EMA-Pediatric-Committee-on-the-Pediatric-Investigation-Plan-for-AEF0217-in-Down-Syndrome
Aelis Farma Receives a Positive Opinion From EMA Pediatric Committee on the Pediatric Investigation...
Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible), a clinical-stage biopharmaceutical company specializing in the developme...
aelis farmaon thereceivespositiveopinion